ABEONA THERAPEUTICS INC (ABEO)
US00289Y2063 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -54.19M | -39.70M | -84.94M | -84.23M | -76.28M | |||
| Depreciation Amortization | 2.29M | 3.09M | 3.25M | 4.59M | 7.82M | |||
| Change In Working Capital | -1.79M | -5.89M | -18.26M | 1.63M | -3.55M | |||
| Interest Paid | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Taxes Paid | N/A | N/A | 0.00 | N/A | N/A | |||
| Other non cash items | 16.68M | -990.00K | 34.28M | 43.00M | 9.20M | |||
| OPERATING CASH FLOW | -37.01M | -43.48M | -65.67M | -35.02M | -62.82M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -331.00K | -130.00K | -4.15M | -1.34M | -6.51M | |||
| Other Investing Activity | 539.00K | -23.83M | 70.21M | -82.38M | 66.48M | |||
| INVESTING CASH FLOW | 208.00K | -23.96M | 66.06M | -83.71M | 59.98M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 1.76M | N/A | |||
| Stock Issued/Repurchased | 37.21M | 43.17M | 24.86M | 180.00K | 113.90M | |||
| Other Financing Activity | -150.00K | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 37.06M | 43.17M | 24.86M | 1.94M | 113.90M | |||
| CHANGE IN CASH | 256.00K | -24.27M | 25.25M | -116.79M | 111.06M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -37.01M | -43.48M | -65.67M | -35.02M | -62.82M | |||
| Capital Expenditure | -331.00K | -130.00K | -4.15M | -1.34M | -6.51M | |||
| FREE CASH FLOW | -37.34M | -43.61M | -69.82M | -36.36M | -69.33M | |||
All data in USD